D-0131-2020 Class III Terminated

Recalled by Teva Pharmaceuticals USA — Parsippany, NJ

Recall Details

Product Type
Drugs
Report Date
October 16, 2019
Initiation Date
September 6, 2019
Termination Date
May 19, 2020
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
5,849 bottles

Product Description

Matzim LA (Diltiazem Hydrochloride) Extended-Release Tablets, 240 mg, 30 count bottle, Rx only, Manufactured by: Actabis Laboratories FL, Inc., Fort Lauderdale, FL, Distributed by: Actavis Pharma, Inc., Parsippany, NJ NDC 52544-692-30

Reason for Recall

GMP Deviation: lot not intended for commercial distribution.

Distribution Pattern

Product was distributed to 42 wholesalers and 11 retailers who may have further distribute the product throughout the United States, including Hawaii and Puerto Rico.

Code Information

Lot # 1344864A, exp. date 10/2020